Mixed microencapsulation of rat primary hepatocytes and Sertoli cells improves the metabolic function in a D-galactosamine and lipopolysaccharide-induced rat model of acute liver failure
- 1 January 2009
- journal article
- Published by Elsevier in Cytotherapy
- Vol. 11 (3) , 326-329
Abstract
Hepatocyte transplantation is an alternative to transplantation of the whole liver. Compared with xenogeneic hepatocytes, primary hepatocytes have some advantages, such as a more powerful function and a smaller frequency of rejection caused by the host. Cell microencapsulation prevents direct access of host cells to the graft but cannot impede transfer of transplant-derived peptides, which can cross the physical barrier. Sertoli cells are central to the immune privilege demonstrated in the testis, and their actions have been utilized to protect cell transplants. Co-microencapsulating Sertoli cells with HepG2 cells has proved to be a valuable strategy in hepatocyte transplantation. Thus mixed microcapsules of primary rat hepatocytes and primary Sertoli cells may improve metabolic function in a d-galactosamine and lipopolysaccharide-induced rat model of acute liver failure.Keywords
This publication has 11 references indexed in Scilit:
- Microencapsule technique protects hepatocytes from cryoinjuryHepatology Research, 2008
- Liver transplantation: an update 2007Current Opinion in Gastroenterology, 2007
- Microencapsulating HepatocytesTransplantation Proceedings, 2005
- Treatment of fulminant liver failure by transplantation of microencapsulated primary or immortalized xenogeneic hepatocytesTransplantation Proceedings, 2005
- Survival after liver transplantation in the United States: A disease-specific analysis of the UNOS databaseLiver Transplantation, 2004
- History, challenges and perspectives of cell microencapsulationTrends in Biotechnology, 2004
- Hepatocyte Transplantation in the Treatment of Acute Liver Failure: Microencapsulated Hepatocytes versus Hepatocytes Attached to an Autologous BiomatrixCell Transplantation, 2003
- A Bioartificial Liver--State of the ArtScience, 2002
- Long-Term Culture of Glutamine Synthetase-Transfected HepG2 Cells in Circulatory Flow Bioreactor for Development of a Bioartificial LiverCell Transplantation, 2000
- Acute liver failure: Targeted artificial and hepatocyte-based support of liver regeneration and reversal of multiorgan failureJournal of Hepatology, 2000